Purchases and Sales Made in Q2 2023 in Lucid Diagnostics Inc. (LUCD)
This table provides information about the institutional ownership of Lucid Diagnostics Inc. (LUCD) during Q2 2023. The information is specifically focused on institutions that hold shares of Lucid Diagnostics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
102K+ 245.34% |
$130K - $181K
|
143K
$143K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
62.5KNew |
$80K - $111K
|
62.5K
$62.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Luminus Management LLC
Houston, TX |
BUY
|
- |
23.1K+ 2.7% |
$29.5K - $41.1K
|
878K
$878K
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
7.45K+ 39.5% |
$9.53K - $13.3K
|
26.3K
$26.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
400+ 0.13% |
$512 - $712
|
320K
$320K
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
95New |
$122 - $169
|
95
$95
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
35+ 59.32% |
$44.8 - $62.3
|
94
$94
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 75.0% |
$768 - $1.07K
|
200
$200
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.07K- 99.13% |
$3.92K - $5.46K
|
27
$27
|
|
|
Aug 14, 2023
Q2 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-14.3K- 28.33% |
$18.3K - $25.4K
|
36.2K
$36.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-62.6K- 23.92% |
$80.1K - $111K
|
199K
$199K
|